Elicera Therapeutics will participate in upcoming industry and investor conferences during the fall

Gothenburg, September 3, 2024 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next generation cancer treatments based on CAR T-cell therapies and oncolytic viruses, armed with its proprietary and commercially available technology platform iTANK, announces that the company will participate in the following industry and investor conferences during the fall of 2024:

ISCT Europe 2024 Regional Meeting, September 4 
Elicera Therapeutics will participate in the annual conference organized by the scientific network International Society for Gene & Cell Therapy. For more information: https://www.isctglobal.org/iscteu2024/home

CICON24 (Eighth International Cancer Immunotherapy Conference), September 8 
Elicera Therapeutics' co-founder and CSO, Magnus Essand, has been invited to present iTANK and the company’s development of CAR T-cell therapies. For more information: www.cancerimmunotherapyconference.org

Biostock Investor Meeting, September 12 
Elicera Therapeutics' CEO, Jamal El-Mosleh, will present the company at an investor meeting organized by Biostock. For more information: https://www.biostock.se/investing-in-life-science/

NLSDays 2024, September 18–19 
Elicera Therapeutics will participate in Nordic Life Science Days, the Nordic region's largest business conference in life science. For more information: www.nlsdays.com/about-the-event

Miltenyi Cell and Gene Therapy Summit 2024, October 8 
Elicera Therapeutics' co-founder and CSO, Magnus Essand, has been invited to present iTANK and the company’s development of CAR T-cell therapies. For more information: www.miltenyibiotec.com/UN-en/about-us/conferences-and-events/miltenyi-biotec-s-cell-and-gene-therapy-days.html

BIO-EUROPE, November 4 
Elicera Therapeutics will participate in Europe’s largest business conference in life science. For more information: www.informaconnect.com/bioeurope

Biostock Summit, November 19 
Elicera Therapeutics will present at the annual investor meeting organized by Biostock. The company’s presentation will be published on their website.